MedPath
HSA Approval

AMLOTENS TABLET 10MG

SIN13785P

AMLOTENS TABLET 10MG

AMLOTENS TABLET 10MG

April 9, 2010

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Sanofi Ilac Sanayi ve Ticaret Anonim Sirketi

SIEGFRIED LTD

SIEGFRIED MALTA LTD

Active Ingredients

AMLODIPINE MESILATE MONOHYDRATE 12.79 mg EQV AMLODIPINE BASE

10 mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMLOTENS TABLET 10MG - HSA Approval | MedPath